Suchergebnisse - "Sarilumab"

PubPharm (81)

41

Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis : A Japan phase 3 trial (HARUKA)

enthalten in: Modern rheumatology | 2020

von Kameda, H. | Wada, K. | Takahashi, Y. | +4

42

Long-term safety of sarilumab in rheumatoid arthritis : an integrated analysis with up to 7 years' follow-up

enthalten in: Rheumatology (Oxford, England) | 2020

von Fleischmann, R. | Genovese, M. | Lin, Y. | +8

43

Population Pharmacokinetics of Sarilumab in Patients with Rheumatoid Arthritis

enthalten in: Clinical pharmacokinetics | 2019

von Xu, C. | Su, Y. | Paccaly, A. | +1

44

Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors

enthalten in: Journal of managed care & specialty pharmacy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5

45

Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2019

von Choy, E.

46

Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale

enthalten in: The Journal of rheumatology | 2019

von Gossec, L. | Strand, V. | Proudfoot, C. | +6

47

Efficacy of sarilumab in adult-onset Still's disease as a corticosteroid-sparing agent

enthalten in: Rheumatology (Oxford, England) | 2019

von Simeni Njonnou, S. | Soyfoo, M. | Vandergheynst, F.

48

Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs

enthalten in: Advances in therapy | 2019

von Muszbek, N. | Proudfoot, C. | Fournier, M. | +5

49

Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2019

von Emery, P. | Rondon, J. | Parrino, J. | +8

50

Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs

enthalten in: Advances in therapy | 2019

von Choy, E. | Freemantle, N. | Proudfoot, C. | +7